524 related articles for article (PubMed ID: 15916756)
1. Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.
Qvigstad E; Sjaastad I; Bøkenes J; Schiander I; Solberg L; Sejersted OM; Osnes JB; Skomedal T
Eur J Pharmacol; 2005 May; 516(1):51-9. PubMed ID: 15916756
[TBL] [Abstract][Full Text] [Related]
2. Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure.
Sjaastad I; Schiander I; Sjetnan A; Qvigstad E; Bøkenes J; Sandnes D; Osnes JB; Sejersted OM; Skomedal T
Acta Physiol Scand; 2003 Apr; 177(4):449-58. PubMed ID: 12648162
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol blockade of rat myocardial alpha1-adrenoceptors.
Qvigstad E; Osnes JB; Sandnes D; Schiander I; Bøkenes J; Sjaastad I; Skomedal T
Eur J Pharmacol; 2003 Nov; 481(1):83-9. PubMed ID: 14637179
[TBL] [Abstract][Full Text] [Related]
4. Comparison between alpha-1 adrenoceptor-mediated and beta adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle.
Skomedal T; Borthne K; Aass H; Geiran O; Osnes JB
J Pharmacol Exp Ther; 1997 Feb; 280(2):721-9. PubMed ID: 9023284
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol induces greater control of β2- than β 1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium.
Molenaar P; Christ T; Berk E; Engel A; Gillette KT; Galindo-Tovar A; Ravens U; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):629-40. PubMed ID: 24668024
[TBL] [Abstract][Full Text] [Related]
7. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
[TBL] [Abstract][Full Text] [Related]
8. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
Chen J; Zhang LF; Han C; Yu GS; Ma J
J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
[TBL] [Abstract][Full Text] [Related]
9. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological study on functional significance of alpha 1-adrenoceptor subtypes in mammalian ventricular myocardium].
Nagashima M
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):940-52. PubMed ID: 7959601
[TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
Nichols AJ; Gellai M; Ruffolo RR
Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
[TBL] [Abstract][Full Text] [Related]
13. Blockade of putative beta4- and beta1-adrenoceptors by carvedilol in ferret myocardium.
Lowe MD; Grace AA; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 1999 May; 359(5):400-3. PubMed ID: 10498290
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart.
Molenaar P; Christ T; Ravens U; Kaumann A
Cardiovasc Res; 2006 Jan; 69(1):128-39. PubMed ID: 16225854
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
Hryniewicz K; Androne AS; Hudaihed A; Katz SD
Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
[TBL] [Abstract][Full Text] [Related]
16. In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol.
Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
Pharmacology; 1989; 39(5):327-36. PubMed ID: 2575762
[TBL] [Abstract][Full Text] [Related]
17. Alpha and beta adrenoceptor blocking action of carvedilol in the canine mesenteric artery and vein.
Seki N; Nagao T; Komori K; Suzuki H
J Pharmacol Exp Ther; 1988 Sep; 246(3):1116-22. PubMed ID: 2901485
[TBL] [Abstract][Full Text] [Related]
18. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
[TBL] [Abstract][Full Text] [Related]
19. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
[TBL] [Abstract][Full Text] [Related]
20. beta-Adrenoceptors potentiate alpha1-adrenoceptor-mediated inotropic response in rat left atria.
Zhang YZ; Zhang YY; Chen MZ; Han QD
Acta Pharmacol Sin; 2004 Jan; 25(1):29-34. PubMed ID: 14704119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
